Study to Evaluate Bone and Gum Dimension Changes Around Dental Implants Placed in Different Positions in Bone.

Inclusion Criteria

• Subjects must have read, understood and signed an informed consent form;
• Subjects must be 18 to 70 years of age;
• Subjects must be able and willing to follow study procedures and instructions;
• Subjects must have indication to receive two implants in a bilateral maxillary or mandibular edentulous areas (for at least 4 months post extraction) in areas of pre-molars (first or second) and molars (first or second);
• Sufficient width and height of bone to place at least 8mm length and any compatible in diameter Ankylos implant;
• Sufficient vertical clearance to place a single tooth crown replacement;
• No apical disorder/inflammation at the area of the implant site.

Exclusion Criteria

• Subjects participating in other clinical studies within 1 month prior to screening and/or involving therapeutic intervention (either medical or dental) that could affect bone or soft tissue healing;
• Female subjects who are pregnant or lactating, or who intend to become pregnant during the study period following entrance into the study;
• Subjects with parafunctional habits;
• Subjects who have failed to maintain good plaque control;
• Subjects with any systemic condition like uncontrolled diabetes mellitus, cancer, HIV, disorders that compromise wound healing, chronic high dose steroid therapy, bone metabolic diseases, radiation or other immuno-suppressive therapy which would preclude periodontal surgery;
• Absence of occlusal stability in centric occlusion;
• Subjects with the presence of acute infectious lesions in the areas intended for surgery;
• History within the last 3 months of weekly or more frequent use of smokeless chewing tobacco, pipe or cigar smoking and cigarette smoking (greater than 10 cigarettes per day)
• Present alcohol or drug abuse;
• Angulation requirements of the restoration exceeding approximately 15 degrees;
• Systemic corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration (e.g. calcium channel blocker, dilantin).